Skip to main content
. 2020 Jul 31;13(7):100441. doi: 10.1016/j.waojou.2020.100441

Table 2.

Frequency and rate of answers to Q30 and Q31

Question Answers Frequency Rate
Q30. What is your preferred therapeutic option in a severe allergic asthma patient with an incomplete response to Anti-IgE and blood Eos≥150? To add an Anti IL-5 drug 80 28.1%
To switch to an anti IL5 111 38.9%
Neither of the above 28 9.8%
I have not yet formed an opinion 66 23.2%
Q31. What is your preferred therapeutic option in a severe allergic asthma with an incomplete clinical response to anti-IL5 and Eos ≥150 To add an Anti IgE drug 113 39.6%
To switch to another Anti IL5 54 18.9%
Neither of the above 26 9.1%
I have not yet formedan opinion 92 32.3%

Legend: Eos = Eosinophil; IL5 = interleukine 5, IgE = Immunoglobulin E.